The DYVS take place on Wednesdays from 16:00-17:00 via Zoom.

We are always looking for enthusiastic speakers for upcoming seminars. Interested? See: KNVM Virology - Abstract submission

Upcoming seminars 2024:

Wednesday 21 February

Wednesday 17 April

Wednesday 19 June

Wednesday 18 September

Wednesday 20 November

Past seminars 2023

15 November 2023

Mass photometry as a tool to study viral proteins interactions

Tereza Kadavá, Utrecht University 

Unraveling the role of heat shock protein 70 machines during CHIKV infections

Marleen van der Laan, University Medical Center Groningen

13 September 2023

Developing a nanobody toolkit to study the enterovirus 2C protein

Meryl Haas, Utrecht University

Bacteriophage therapy for burn wound infections

Michèle Molendijk, Erasmus MC

Wednesday 28 June

A profile of anti-viral antibody features associated with reduced disease progression in individuals with untreated HIV-1

Marloes Grobben, Amsterdam UMC

Antibody sequencing  

Douwe Schulte, Utrecht University

12 April 2023

​​​​​​​Mathematical modeling to understand the therapeutic response to oncolytic viruses

Darshak Bhatt, UMC Groningen

Transient Improvement of Fulminant Subacute Sclerosing Panencephalitis after Experimental Treatment with Remdesivir

Katharina Schmitz, Erasmus MC

15 February 2023

Dynamic immunodominance profiles of SARS-CoV-2 specific CD8+ T memory cells in convalescent donors

Jet van den Dijssel, Sanquin Research and Landsteiner Laboratory, AMC

Local and systemic transcriptomic profiling of monocytes shows host- pathogen interactions in children experiencing severe RSV infection

Klasina Chappin, UMC Utrecht

Past seminars 2022

30 November 2022

Unexpected use of human-type sialic acid receptors by avian influenza A viruses

Mengying Liu, Utrecht Univerisity

Understanding the complexity of DENV-induced inflammation and its impact on the course of disease

Bram ter Ellen, UMC Groningen

28 September 2022

Structural insights into host-pathogen interactions of Herpesvirus glycoprotein B and Myelin-associated Glycoprotein

Sabrina Krepel, Utrecht University

RNA recombination between self-amplifying mRNA vaccines and wild-type alphaviruses

Tessy Hick, Wageningen University & Research

22 June 2022

Intra-host evolution of human Norovirus during chronic infections and insights into the outcome of immunoglobulin treatment

Ray Izquierdo Lara, Erasmus MC

Persistent infection of seasonal and pandemic influenza viruses in a hiPSC-derived neural model

Feline Benavides, Erasmus MC

20 April 2022 

Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns

Ilhan Tomris, Utrecht University

Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women

Ninée Buchholtz, UMC Utrecht 

16 February 2022

Non-human primate adenoviruses of the Human Adenovirus B species are potent and broadly-acting oncolytic vector candidates

Selas Bots, LUMC 

SARS-CoV-2 Omicron-specific humoral and cellular immunity in COVID-19 vaccinees

Daryl Geers, Erasmus MC 

Past seminars 2021

17 November 2021 

Diversity and long-term dynamics of human blood anelloviruses

Joanna Kaczorowska, WUR 

Two-component nanoparticle vaccine displaying glycosylated SARS-CoV-2 spike S1 domain produced in insect cells

Linda van Oosten, Amsterdam UMC

20 October 2021 

mRNA vaccination boosts existing cellular responses and enhances protection against lethal H7N9 challenge in ferrets

Koen van de Ven, RIVM

Macrocyclic peptides targeting the hemagglutinin stem region potently inhibit H1 and H5 influenza A viruses

Mirte Pascha, Utrecht University 

15 September 2021 

Antiviral and immunoregulatory effects of LL-37 against dengue infection in macrophages

Jorge Andrés Castillo, UMC Groningen 

Analysis of influenza virus specific B cells reveals a diverse set of antibodies towards different domains of the influenza virus hemagglutinin

Aafke Aartse, BPRC

16 June 2021  

Identification of a novel inhibitor of Zika virus replication

Bodine Bezemer, Radboud UMC  

SARS-CoV-2 does not trigger TLR4

Lieve van der Donk, Amsterdam UMC  

19 May 2021  

Varicella-zoster virus VLT and VLT-ORF63 proteins are dispensable for lytic infection in cell culture

Shirley Braspenning, Erasmus MC

SARS-CoV-2 Infection Depends on Heparan Sulfates and Is Blocked by Low Molecular Weight Heparins

Julia Eder, Amsterdam UMC